Breaking News Instant updates and real-time market news.

VSTM

Verastem

$3.36

0.1 (3.07%)

07:08
02/07/18
02/07
07:08
02/07/18
07:08

Verastem submits NDA for Develisib to FDA

Verastem announced it has submitted a New Drug Application to the U.S. FDA seeking full approval for its lead product candidate duvelisib, a first-in-class oral dual inhibitor of phosphoinositide-3-kinase-delta and PI3K-gamma, for the treatment of relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma and accelerated approval for the treatment of relapsed or refractory follicular lymphoma. Duvelisib has received Fast Track Designation from the FDA for patients with CLL or peripheral T-cell lymphoma who have received at least one prior therapy and for patients with FL who have received at least two prior therapies. In addition, duvelisib received orphan drug designation in the United States and the European Union for patients with CLL, SLL and FL. The NDA is supported by clinical data from the randomized Phase 3 DUO study demonstrating significant efficacy, along with a consistent and manageable safety profile, of duvelisib monotherapy in patients with relapsed or refractory CLL/SLL. The DUO study met its primary endpoint with oral duvelisib monotherapy achieving a statistically significant improvement in progression-free survival compared to ofatumumab in patients with relapsed or refractory CLL/ SLL, representing a 48% reduction in the risk of disease progression or death. The NDA is also supported by results from the Phase 2 DYNAMO(TM) study in patients with indolent non-Hodgkin's lymphoma that are double-refractory to both rituximab and chemotherapy or radioimmunotherapy, which also achieved its primary endpoint with an objective response rate of 46%. In the subset of patients enrolled in DYNAMO with double-refractory FL, duvelisib demonstrated an ORR of 41%.

VSTM Verastem
$3.36

0.1 (3.07%)

12/11/17
OPCO
12/11/17
NO CHANGE
Target $15
OPCO
Outperform
Verastem price target raised to $15 from $6 at Oppenheimer
Oppenheimer analyst Leah Rush Cann raised her price target for Verastem to $15 from $6 to reflect decreased risk of failure, now that details of the DUO data are released. Based on the balance of efficacy and adverse events reported from the DUO study, the analyst continues to expect that Verastem will launch duvelisib in 2019, and it will be the primary revenue and earnings driver for the company. The analyst reiterates an Outperform rating on the shares.
11/30/17
ROTH
11/30/17
INITIATION
Target $12
ROTH
Buy
Verastem initiated with a Buy at Roth Capital
Roth Capital analyst Jotin Marango initiated Verastem with a Buy rating and $12 price target, as he believes full CLL data from the DUO pivotal study at ASH next week should bolster investor confidence in duvelisib ahead of an NDA filing he sees as likely in the first quarter of 2018.
09/06/17
CANT
09/06/17
UPGRADE
Target $17
CANT
Verastem upgraded to Overweight after duvelisib data at Cantor
As previously reported, Cantor Fitzgerald analyst Mara Goldstein upgraded Verastem to Overweight from Neutral after the company reported Phase 3 DUO study data on duvelisib in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma that was "squarely positive" and suggests a viable commercial opportunity. The analyst, who predicts that duvelisib can capture a reasonable market share in both high risk and low/medium risk patients with relapsed/refractory CLL, raised her price target on Verastem shares to $17 from $2.
09/06/17
CANT
09/06/17
UPGRADE
CANT
Overweight
Verastem upgraded to Overweight from Neutral at Cantor

TODAY'S FREE FLY STORIES

SCHW

Charles Schwab

$52.74

0.71 (1.36%)

17:03
02/23/18
02/23
17:03
02/23/18
17:03
Hot Stocks
Charles Schwab appoints Joseph Martinetto as COO of the firm »

On February 22, the board…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KHC

Kraft Heinz

$69.02

1.38 (2.04%)

, BRK.A

Berkshire Hathaway

$304,020.01

2616.01 (0.87%)

17:02
02/23/18
02/23
17:02
02/23/18
17:02
Hot Stocks
Kraft Heinz announces retirement of Warren Buffett from Board of Directors »

The Kraft Heinz Company…

KHC

Kraft Heinz

$69.02

1.38 (2.04%)

BRK.A

Berkshire Hathaway

$304,020.01

2616.01 (0.87%)

BRK.B

Berkshire Hathaway

$202.76

2.03 (1.01%)

BUD

AB InBev

$107.25

1.91 (1.81%)

QSR

Restaurant Brands

$59.46

1.02 (1.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

  • 07

    Mar

  • 18

    Mar

SWX

Southwest Gas

$69.17

1.65 (2.44%)

17:02
02/23/18
02/23
17:02
02/23/18
17:02
Hot Stocks
Southwest Gas increases quarterly common stock dividend »

The board for Southwest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

MS

Morgan Stanley

$56.07

1.21 (2.21%)

, AAOI

Applied Optoelectronics

$28.02

0.51 (1.85%)

16:56
02/23/18
02/23
16:56
02/23/18
16:56
Hot Stocks
Breaking Hot Stocks news story on Morgan Stanley, Applied Optoelectronics »

Morgan Stanley reports…

MS

Morgan Stanley

$56.07

1.21 (2.21%)

AAOI

Applied Optoelectronics

$28.02

0.51 (1.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 25

    Feb

  • 12

    Mar

  • 13

    Mar

  • 29

    Mar

HSBC

HSBC

$51.23

0.19 (0.37%)

16:49
02/23/18
02/23
16:49
02/23/18
16:49
Syndicate
Breaking Syndicate news story on HSBC »

HSBC files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

X

U.S. Steel

$43.52

0.54 (1.26%)

, AKS

AK Steel

$5.50

-0.12 (-2.14%)

16:48
02/23/18
02/23
16:48
02/23/18
16:48
Periodicals
Breaking Periodicals news story on U.S. Steel, AK Steel »

Trump said to want 24%…

X

U.S. Steel

$43.52

0.54 (1.26%)

AKS

AK Steel

$5.50

-0.12 (-2.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PPL

PPL Corp.

$30.34

0.82 (2.78%)

16:36
02/23/18
02/23
16:36
02/23/18
16:36
Syndicate
PPL Corp. files to sell $1B of common stock »

J.P. Morgan Securities,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 16

    May

L

Loews

$50.34

0.74 (1.49%)

16:33
02/23/18
02/23
16:33
02/23/18
16:33
Syndicate
Breaking Syndicate news story on Loews »

Loews files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

GBL

GAMCO Investors

$27.26

1.56 (6.07%)

, CHE

Chemed

$261.22

5.59 (2.19%)

16:31
02/23/18
02/23
16:31
02/23/18
16:31
Hot Stocks
Breaking Hot Stocks news story on GAMCO Investors, Chemed »

Gabelli reports 4.28%…

GBL

GAMCO Investors

$27.26

1.56 (6.07%)

CHE

Chemed

$261.22

5.59 (2.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
02/23/18
02/23
16:30
02/23/18
16:30
Options
Preliminary option volume of 19.2M today »

Preliminary option volume…

CTO

Consolidated Tomoka

$62.60

0.73 (1.18%)

16:24
02/23/18
02/23
16:24
02/23/18
16:24
Hot Stocks
Consolidated Tomoka acquires net lease property in Aspen, CO for $26.5M »

Consolidated-Tomoka Land…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

HPE

HP Enterprise

$18.14

1.73 (10.54%)

, HPQ

HP Inc.

$22.13

0.74 (3.46%)

16:21
02/23/18
02/23
16:21
02/23/18
16:21
General news
On The Fly: Top stock stories for Friday »

Stocks opened in positive…

HPE

HP Enterprise

$18.14

1.73 (10.54%)

HPQ

HP Inc.

$22.13

0.74 (3.46%)

BUFF

Blue Buffalo Pet Products

$40.00

5.88 (17.23%)

GIS

General Mills

$52.98

-1.97 (-3.59%)

JWN

Nordstrom

$53.56

3.29 (6.54%)

MOMO

Momo

$35.75

5.22 (17.10%)

TTD

Trade Desk

$59.94

11.54 (23.84%)

KMPH

KemPharm

$6.00

0.738 (14.03%)

GOGO

Gogo

$8.88

-0.25 (-2.74%)

AAL

American Airlines

$53.39

0.41 (0.77%)

OLED

Universal Display

$130.40

-24.5 (-15.82%)

FSLR

First Solar

$61.79

-4.49 (-6.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 25

    Feb

  • 26

    Feb

  • 26

    Feb

  • 27

    Feb

  • 01

    Mar

  • 04

    Mar

  • 05

    Mar

  • 06

    Mar

  • 06

    Mar

  • 07

    Mar

  • 08

    Mar

  • 11

    Mar

  • 12

    Mar

  • 15

    Mar

  • 18

    Mar

  • 24

    Apr

  • 30

    May

VIX

Volatility Index S&P 500 Options

16:20
02/23/18
02/23
16:20
02/23/18
16:20
Options
Closing CBOE SPX and VIX Index summary for February 23rd »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SEMG

SemGroup

$25.50

1.5 (6.25%)

, VLO

Valero

$92.46

0.41 (0.45%)

16:18
02/23/18
02/23
16:18
02/23/18
16:18
Hot Stocks
SemGroup to sell SemLogistics business unit to Valero »

SemGroup (SEMG) announced…

SEMG

SemGroup

$25.50

1.5 (6.25%)

VLO

Valero

$92.46

0.41 (0.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

$NSD

NASDAQ Market Internals

16:17
02/23/18
02/23
16:17
02/23/18
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

16:16
02/23/18
02/23
16:16
02/23/18
16:16
Technical Analysis
NYSE market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WEN

Wendy's

16:11
02/23/18
02/23
16:11
02/23/18
16:11
Hot Stocks
Breaking Hot Stocks news story on Wendy's »

Eminence Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Mar

  • 30

    May

IRIX

IRIDEX

$7.41

0.21 (2.92%)

16:09
02/23/18
02/23
16:09
02/23/18
16:09
Earnings
Breaking Earnings news story on IRIDEX »

IRIDEX sees FY17 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Mar

  • 11

    Mar

IRIX

IRIDEX

$7.41

0.21 (2.92%)

16:09
02/23/18
02/23
16:09
02/23/18
16:09
Earnings
Breaking Earnings news story on IRIDEX »

IRIDEX sees Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Mar

  • 11

    Mar

HTZ

Hertz

$20.65

0.085 (0.41%)

, SYMC

Symantec

$27.43

0.45 (1.67%)

16:07
02/23/18
02/23
16:07
02/23/18
16:07
Hot Stocks
Corporate pressure on NRA builds as more companies cut ties »

The National Rifle…

HTZ

Hertz

$20.65

0.085 (0.41%)

SYMC

Symantec

$27.43

0.45 (1.67%)

MET

MetLife

$47.41

0.78 (1.67%)

CB

Chubb

$143.76

0.69 (0.48%)

AOBC

American Outdoor Brands

$10.00

-0.12 (-1.19%)

RGR

Sturm, Ruger

$49.80

0.8 (1.63%)

VSTO

Vista Outdoor

$18.19

-0.23 (-1.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 26

    Feb

  • 26

    Feb

  • 28

    Feb

  • 01

    Mar

  • 06

    Mar

  • 13

    Mar

  • 14

    Mar

  • 12

    Jun

NNA

Navios Acquisition

$0.74

-0.0135 (-1.79%)

16:06
02/23/18
02/23
16:06
02/23/18
16:06
Hot Stocks
Navios Acquisition receives continue listing standards notice from NYSE »

Navios Acquisition…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IRIX

IRIDEX

$7.41

0.21 (2.92%)

16:06
02/23/18
02/23
16:06
02/23/18
16:06
Hot Stocks
IRIDEX issues voluntary recall of TruFocus LIO Premiere ophthalmoscope »

On February 23, IRIDEX…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Mar

  • 11

    Mar

GBL

GAMCO Investors

$25.75

0.05 (0.19%)

15:57
02/23/18
02/23
15:57
02/23/18
15:57
Hot Stocks
GAMCO Investors up over 5% after Gabelli waives compensation »

Earlier, GAMCO Investors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SCBFF

Standard Chartered

$11.56

0.13 (1.14%)

15:56
02/23/18
02/23
15:56
02/23/18
15:56
Conference/Events
Standard Chartered management to meet with JPMorgan »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

NOAH

Noah Holdings

$48.94

2.14 (4.57%)

15:52
02/23/18
02/23
15:52
02/23/18
15:52
Conference/Events
Noah Holdings management to meet with JPMorgan »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.